Officials Talk Shop at BioInc@NYMC
Mr. Zemsky was appointed by Governor Cuomo to lead New York State's economic development program, including a newly announced $650 million life sciences initiative
New York State Senator Terrence P. Murphy, second from left, invited Empire State Development (ESD) President, Chief Executive Officer and Commissioner Howard Zemsky, third from left, for a visit at BioInc@NYMC on February 27. Mr. Zemsky was appointed by Governor Cuomo to lead New York State's economic development program, including a newly announced $650 million life sciences initiative. BioInc@ NYMC has received priority designation and funding in earlier budget cycles in concert with federal, county, and private support. Joining the visit clockwise from left were: Robert W. Amler, M.D., M.B.A., vice president for government affairs and dean of the School of Health Sciences and Practice; Randi D. Schwartz, M.B.A., director of BioInc@NYMC and associate dean for academic administration, School of Medicine; Barry Kappel, Ph.D., M.B.A., president and chief executive officer of Sapience Therapeutics Inc., a growing client-firm at BioInc@NYMC; and D. Douglas Miller, M.D., C.M., M.B.A., chief scientific officer at BioInc@NYMC and dean of the School of Medicine.
